Meglitinides are oral medications used to treat type 2 diabetes. They work by triggering production of insulin. Medications in this class include Prandin (repaglinide) and Starlix (nateglinide).
What is the difference between sulfonylureas and meglitinides?
The main difference between sulfonylureas and meglitinides is that meglitinides have a rapid onset of action as well as a short duration of activity. This makes meglitinides ideal for patients with postprandial hyperglycemia. Thus these drugs are taken just before meals to reduce postprandial hyperglycemia.
What is another name for meglitinides?
Meglitinides (eg, repaglinide, nateglinide) are much shorter-acting insulin secretagogues than the sulfonylureas are, with preprandial dosing potentially achieving more physiologic insulin release and less risk for hypoglycemia.
What is a meglitinide agent?
The meglitinide analogues (“meglitinides”) are a class of oral antidiabetic agents that increase insulin secretion in the pancreas. The properties of this class of drug suggest that they have the potential to produce a rapid, short-lived insulin output.
What is amylin analog?
This agent is a synthetic analogue of human amylin, a naturally occurring hormone made in pancreatic beta cells. It slows gastric emptying, suppresses postprandial glucagon secretion, and regulates food intake through centrally mediated appetite modulation.
What class is Byetta?
Byetta belongs to a class of drugs called Antidiabetics, Glucagon-like Peptide-1 Agonists. It is not known if Byetta is safe and effective in children.
Does meglitinide cause hypoglycemia?
The use of meglitinides increased the risk of hypoglycemia (HR, 1.94, p<0.001), as did other anti-diabetic agents. Concomitant use of meglitinide and insuilin will incresase the hypoglycemic risk.
What happened amylin Pharmaceuticals?
The company was engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases….Amylin Pharmaceuticals.
| Type | Subsidiary |
|---|---|
| Founded | 1987 |
| Defunct | 2012 |
| Fate | Acquired by Bristol-Myers Squibb and AstraZeneca |
| Headquarters | San Diego, California, United States |
What are megglitinides used for?
Meglitinides are a class of medications that are prescribed to people with type 2 diabetes to take before every meal. They help the insulin-producing beta cells in the pancreas to release insulin. Here are the meglitinides on the market with the available brand names in parenthesis:
What is meglitinide (Prandin)?
Meglitinides or glinides are a class of drugs used to treat type 2 diabetes. Repaglinide (trade name Prandin) gained US Food and Drug Administration approval in 1997. Other drugs in this class include nateglinide (Starlix) and mitiglinide (Glufast). Side effects include weight gain and hypoglycemia.
Are meglitinides safe for the elderly?
Meglitinides have been approved by the FDA for the treatment of type 2 diabetes since 1997. They can be used alone or in combination with other medications. This class of medication is tolerated well in the elderly who need help lowering their mealtime blood sugars. Meglitinides can also be expensive.
What are the most common side effects of meglitinides?
Low blood sugar ( hypoglycemia) is the most common side effect of meglitinides. Symptoms of hypoglycemia include sweating, shakiness, lightheadedness, and possible confusion. Meglitinides are relatively short-acting medications, which means that they have a lower risk of producing hypoglycemia.
